'A lot of people swear by it' -Trump on hydroxychloroquine

“The system we have here in the United States is that, once a drug is approved and on the market, a doctor in consultation with a patient may use it for what we call off-label purposes, which are indications that are not yet proven and not yet in the label. And this is the right-to-try president,” Azar said during a cabinet meeting with Trump.​

The U.S. Food and Drug Administration has warned about potential serious side effects with the use of the drug in COVID-19 patients.